Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways

Z Zhu, AJR McGray, W Jiang, B Lu, P Kalinski, ZS Guo - Molecular cancer, 2022 - Springer
Oncolytic viruses (OVs) represent a new class of multi-modal immunotherapies for cancer,
with OV-elicited antitumor immunity being key to their overall therapeutic efficacy. Currently …

Signaling pathways in macrophages: molecular mechanisms and therapeutic targets

M Li, M Wang, Y Wen, H Zhang, GN Zhao, Q Gao - MedComm, 2023 - Wiley Online Library
Macrophages play diverse roles in development, homeostasis, and immunity. Accordingly,
the dysfunction of macrophages is involved in the occurrence and progression of various …

Targeting the tumor microenvironment in neuroblastoma: recent advances and future directions

S Joshi - Cancers, 2020 - mdpi.com
Neuroblastoma (NB) is the most common pediatric tumor malignancy that originates from the
neural crest and accounts for more than 15% of all the childhood deaths from cancer. The …

[HTML][HTML] Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy

S Joshi, A Sharabi - Pharmacology & therapeutics, 2022 - Elsevier
Myeloid-derived suppressor cells (MDSCs) are immune cells of the myeloid lineage that
progressively accumulate in tumors and play an important role in promoting tumor growth …

“Re-educating” tumor associated macrophages as a novel immunotherapy strategy for neuroblastoma

KX Liu, S Joshi - Frontiers in immunology, 2020 - frontiersin.org
Neuroblastoma is the most common extracranial pediatric tumor and often presents with
metastatic disease, and patients with high-risk neuroblastoma have survival rates of~ 50 …

SIGLEC15 amplifies immunosuppressive properties of tumor-associated macrophages in pancreatic cancer

TJ Li, KZ Jin, H Li, LY Ye, PC Li, B Jiang, X Lin, ZY Liao… - Cancer Letters, 2022 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) usually presents infrequent infiltration of T
lymphocytes. The known immune-checkpoint inhibitors to date focus on activating T cells …

Investigational spleen tyrosine kinase (SYK) inhibitors for the treatment of autoimmune diseases

S Tang, Q Yu, C Ding - Expert opinion on investigational drugs, 2022 - Taylor & Francis
ABSTRACT Introduction Autoimmune diseases (ADs) are disorders induced by multiple
inflammatory mediators, in which immune system attacks healthy tissues and triggers tissue …

Anti-inflammatory activity of extracts and pure compounds derived from plants via modulation of signaling pathways, especially PI3K/AKT in macrophages

A Merecz-Sadowska, P Sitarek, T Śliwiński… - International journal of …, 2020 - mdpi.com
The plant kingdom is a source of important therapeutic agents. Therefore, in this review, we
focus on natural compounds that exhibit efficient anti-inflammatory activity via modulation …

Bibliometric analysis of ATAC-Seq and its use in cancer biology via nucleic acid detection

Y Zhao, X Zhang, Z Song, D Wei, H Wang… - Frontiers in …, 2020 - frontiersin.org
Assay for transposase-accessible chromatin using sequencing (ATAC-seq) is associated
with significant progress in biological research and has attracted increasing attention …

Targeting macrophage Syk enhances responses to immune checkpoint blockade and radiotherapy in high-risk neuroblastoma

D Rohila, IH Park, TV Pham, R Jones, E Tapia… - Frontiers in …, 2023 - frontiersin.org
Background Neuroblastoma (NB) is considered an immunologically cold tumor and is
usually less responsive to immune checkpoint blockade (ICB). Tumor-associated …